Lancet Neurol. 2004 Feb;3(2):104-10
Dyment DA, Ebers GC, Sadovnick AD.
The Wellcome Trust Center for Human Genetics, University of Oxford, Oxford, UK
Multiple sclerosis (MS) is probably aetiologically heterogeneous.
Systematic genetic epidemiological and molecular genetic studies have provided important insights.
Both genetic and non-genetic (environment, stochastic) factors may be involved in susceptibility as well as outcome, but we have yet to understand their relative roles.
Any environmental factor is likely to be ubiquitous and act on a population-basis rather than within the family microenvironment.
Taken together, the results of genome screening studies provide strong evidence for exclusion of a major locus in MS.
There are, however, many genes that seem to be associated with MS.
These include, but are in no way limited to, HLA classes I and II, T-cell receptor beta, CTLA4, ICAM1, and SH2D2A.
The future of MS genetics, as for most common complex disorders, will be dependent on the resources available, ranging from biological samples and comprehensive databases of clinical and epidemiological information to the development of new technologies and statistical methods.